Skip to main content

Recent Sentinel Activity

This recent activity feed provides a list of the last 90 days of Sentinel activity across assessments, publications & presentations, projects, events, etc.

RSS Feed

URL Title Category Date Recent Activity
https://sentinelinitiative.org/methods-data-tools/methods/advancing-scalable-natural-language-processing-approaches-unstructured Advancing Scalable Natural Language Processing Approaches for Unstructured Electronic Health Record Data Methods, Data, & Tools
Advancing Scalable Natural Language Processing Approaches for Unstructured Electronic Health Record Data
Methods, Data, & Tools
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/racial-differences-covid-19-outcomes-2020-2021 Racial Differences in COVID-19 Outcomes (2020-2021) Assessments
Racial Differences in COVID-19 Outcomes (2020-2021)
Assessments
https://sentinelinitiative.org/news-events/publications-presentations/racial-differences-us-covid-19-positivity-hospitalization Racial Differences in U.S. COVID-19 Positivity, Hospitalization, and Mortality Spotlight
Racial Differences in U.S. COVID-19 Positivity, Hospitalization, and Mortality
Spotlight
https://sentinelinitiative.org/methods-data-tools/methods/medical-literature-and-data-cannabis-use Medical Literature and Data on Cannabis Use Methods, Data, & Tools
Medical Literature and Data on Cannabis Use
Methods, Data, & Tools
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/mortality-following-long-acting-injectable-antipsychotics Mortality Following Long-Acting Injectable Antipsychotics Use: An Inverse Probability of Treatment Weighting Analysis Analyses
Mortality Following Long-Acting Injectable Antipsychotics Use: An Inverse Probability of Treatment Weighting Analysis
Analyses
https://sentinelinitiative.org/news-events/publications-presentations/association-between-race-and-covid-19-outcomes-united-states Association Between Race and COVID-19 Outcomes in the United States (2020-2021) Publications and Presentations
Association Between Race and COVID-19 Outcomes in the United States (2020-2021)
Publications and Presentations
https://sentinelinitiative.org/methods-data-tools/methods/systematic-process-assessing-fitness-purpose-health-outcomes-computable A Systematic Process for Assessing Fitness-for-Purpose of Health Outcomes for Computable Phenotyping with Electronic Health Records Data Methods, Data, & Tools
A Systematic Process for Assessing Fitness-for-Purpose of Health Outcomes for Computable Phenotyping with Electronic Health Records Data
Methods, Data, & Tools
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/covid-19-chart-validation-covid-19-severity-algorithm COVID-19 Chart Validation of COVID-19 Severity Algorithm Methods, Data, & Tools
COVID-19 Chart Validation of COVID-19 Severity Algorithm
Methods, Data, & Tools
https://sentinelinitiative.org/methods-data-tools/sentinel-common-data-model/sentinel-common-data-model Sentinel Common Data Model Methods, Data, & Tools
Sentinel Common Data Model
Methods, Data, & Tools
https://sentinelinitiative.org/methods-data-tools/methods/empirical-application-sentinel-ehr-and-claims-data-partner-network Empirical Application of the Sentinel EHR and Claims Data Partner Network to Enhance ARIA Sufficient Inferential Requests and Atypical Descriptive Requests (Use Case Package 2) Methods, Data, & Tools
Empirical Application of the Sentinel EHR and Claims Data Partner Network to Enhance ARIA Sufficient Inferential Requests and Atypical Descriptive Requests (Use Case Package 2)
Methods, Data, & Tools
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/occurrence-stroke-intracranial-hemorrhage-and-bleeding Occurrence of Stroke, Intracranial Hemorrhage, and Bleeding Outcomes Following Direct Oral Anticoagulant Use in Patients Aged 64 or Younger with Atrial Fibrillation: A Descriptive Analysis Analyses
Occurrence of Stroke, Intracranial Hemorrhage, and Bleeding Outcomes Following Direct Oral Anticoagulant Use in Patients Aged 64 or Younger with Atrial Fibrillation: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characteristics-and-drug-utilization-dabigatran-rivaroxaban Characteristics and Drug Utilization in Dabigatran, Rivaroxaban, and Apixaban Initiators Aged 64 or Younger: A Descriptive Analysis Analyses
Characteristics and Drug Utilization in Dabigatran, Rivaroxaban, and Apixaban Initiators Aged 64 or Younger: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/thromboembolic-stroke-intracranial-hemorrhage-0 Thromboembolic Stroke, Intracranial Hemorrhage, Gastrointestinal Bleeding, and Major Extracranial Bleeding Following Apixaban, Dabigatran, and Rivaroxaban Use in Patients Aged 64 Years and Younger with Atrial Fibrillation: An Inverse Probability of Treatment Weighting Analysis Analyses
Thromboembolic Stroke, Intracranial Hemorrhage, Gastrointestinal Bleeding, and Major Extracranial Bleeding Following Apixaban, Dabigatran, and Rivaroxaban Use in Patients Aged 64 Years and Younger with Atrial Fibrillation: An Inverse Probability of Treatment Weighting Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-hormonal-contraceptives-following-live-birth-or Utilization of Hormonal Contraceptives Following Live-Birth or Stillbirth Delivery: A Descriptive Analysis Analyses
Utilization of Hormonal Contraceptives Following Live-Birth or Stillbirth Delivery: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characteristics-and-rates-diabetic-ketoacidosis-dka-among Characteristics and Rates of Diabetic Ketoacidosis (DKA) Among Users of Sodium-Glucose Co-Transporter 2 (SGLT-2) Inhibitors, Sitagliptin, or Short/Rapid-Acting Insulin: A Descriptive Analysis Analyses
Characteristics and Rates of Diabetic Ketoacidosis (DKA) Among Users of Sodium-Glucose Co-Transporter 2 (SGLT-2) Inhibitors, Sitagliptin, or Short/Rapid-Acting Insulin: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/proportion-incident-syndrome-inappropriate-antidiuretic Proportion of Incident Syndrome of Inappropriate Antidiuretic Hormone Secretion Cases with Evidence of Pulmonary Opportunistic Infections Among New Users of BIC/FTC/TAF: A Descriptive Analysis Analyses
Proportion of Incident Syndrome of Inappropriate Antidiuretic Hormone Secretion Cases with Evidence of Pulmonary Opportunistic Infections Among New Users of BIC/FTC/TAF: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/methods-data-tools/methods/use-case-2-uc2-aim-5-plasmode-simulation-based-quantitative-bias Use Case 2 (UC2) Aim 5: Plasmode Simulation Based Quantitative Bias Analysis (QBA) for Unmeasured Confounding Methods, Data, & Tools
Use Case 2 (UC2) Aim 5: Plasmode Simulation Based Quantitative Bias Analysis (QBA) for Unmeasured Confounding
Methods, Data, & Tools
https://sentinelinitiative.org/studies/drugs/biktarvy-bictegraviremtricitabinetenofovir-alafenamide Biktarvy (Bictegravir/Emtricitabine/Tenofovir Alafenamide) & Signal Identification Studies
Biktarvy (Bictegravir/Emtricitabine/Tenofovir Alafenamide) & Signal Identification
Studies
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-hormonal-contraceptives-following-live-birth-0 Utilization of Hormonal Contraceptives Following Live-Birth or Stillbirth Delivery: A Second Descriptive Analysis Assessments
Utilization of Hormonal Contraceptives Following Live-Birth or Stillbirth Delivery: A Second Descriptive Analysis
Assessments
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-semaglutide-use-self-controlled Outcome Monitoring Following Semaglutide Use: A Self-Controlled Risk Interval Signal Identification Analysis Analyses
Outcome Monitoring Following Semaglutide Use: A Self-Controlled Risk Interval Signal Identification Analysis
Analyses
https://sentinelinitiative.org/news-events/publications-presentations/characterization-and-comparison-structured-and-unstructured Characterization and Comparison of Structured and Unstructured Electronic Health Record Data Mapped to MedDRA for Post-Marketing Surveillance Publications and Presentations
Characterization and Comparison of Structured and Unstructured Electronic Health Record Data Mapped to MedDRA for Post-Marketing Surveillance
Publications and Presentations
https://sentinelinitiative.org/news-events/publications-presentations/systematic-process-assessing-fitness-purpose-health-outcomes A Systematic Process for Assessing Fitness-for-Purpose of Health Outcomes for Computable Phenotyping With Electronic Health Record Data Publications and Presentations
A Systematic Process for Assessing Fitness-for-Purpose of Health Outcomes for Computable Phenotyping With Electronic Health Record Data
Publications and Presentations
https://sentinelinitiative.org/studies/characterization-influenza-complications-among-individuals-diagnosed-influenza-illness-0 Characterization of Influenza Complications Among Individuals Diagnosed with Influenza-Like Illness in Outpatient, Ambulatory, and Emergency Department Settings: A Descriptive Analysis Analyses
Characterization of Influenza Complications Among Individuals Diagnosed with Influenza-Like Illness in Outpatient, Ambulatory, and Emergency Department Settings: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/news-events/publications-presentations/serious-infection-crohns-disease-patients-treated Serious Infection in Crohn's Disease Patients Treated With Ustekinumab: US Food and Drug Administration Active Postmarket Risk Identification and Analysis in the Sentinel Initiative Publications and Presentations
Serious Infection in Crohn's Disease Patients Treated With Ustekinumab: US Food and Drug Administration Active Postmarket Risk Identification and Analysis in the Sentinel Initiative
Publications and Presentations
https://sentinelinitiative.org/methods-data-tools/sentinel-common-data-model/data-quality-review-and-characterization-programs Data Quality Review and Characterization Programs Methods, Data, & Tools
Data Quality Review and Characterization Programs
Methods, Data, & Tools
https://sentinelinitiative.org/methods-data-tools/routine-querying-tools/sentinel-routine-querying-system Sentinel Routine Querying System Methods, Data, & Tools
Sentinel Routine Querying System
Methods, Data, & Tools
https://sentinelinitiative.org/methods-data-tools/routine-querying-tools/sentinel-routine-querying-system-reporting-tool Sentinel Routine Querying System Reporting Tool Methods, Data, & Tools
Sentinel Routine Querying System Reporting Tool
Methods, Data, & Tools
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-ozempic-use-patients-type-2-0 Outcome Monitoring Following Ozempic Use in Patients with Type 2 Diabetes: An Active Comparator Signal Identification Analysis Analyses
Outcome Monitoring Following Ozempic Use in Patients with Type 2 Diabetes: An Active Comparator Signal Identification Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/motegrity-prucalopride Motegrity (Prucalopride) & Signal Identification Studies
Motegrity (Prucalopride) & Signal Identification
Studies
https://sentinelinitiative.org/studies/drugs/trulance-plecanatide Trulance (Plecanatide) & Signal Identification Studies
Trulance (Plecanatide) & Signal Identification
Studies
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-prucalopride-and-plecanatide Outcome Monitoring Following Prucalopride and Plecanatide Use: An Active Comparator Signal Identification Analysis with Alternating Exposure-Comparator Roles Analyses
Outcome Monitoring Following Prucalopride and Plecanatide Use: An Active Comparator Signal Identification Analysis with Alternating Exposure-Comparator Roles
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/risk-gastrointestinal-hypomotility-constipation-or-gi Risk of Gastrointestinal Hypomotility, Constipation, or GI Dysmotility with Serious Complications and Intentional Self-Harm in Individuals with Migraine Following Use of CGRP Inhibitors: A Propensity Score Matched Analysis Analyses
Risk of Gastrointestinal Hypomotility, Constipation, or GI Dysmotility with Serious Complications and Intentional Self-Harm in Individuals with Migraine Following Use of CGRP Inhibitors: A Propensity Score Matched Analysis
Analyses
https://sentinelinitiative.org/news-events/publications-presentations/expedited-chart-review-process-large-database-studies-using An Expedited Chart Review Process for Large Database Studies Using Natural Language Processing and Multi-Wave Adaptive Sampling Publications and Presentations
An Expedited Chart Review Process for Large Database Studies Using Natural Language Processing and Multi-Wave Adaptive Sampling
Publications and Presentations
https://sentinelinitiative.org/studies/drugs/calcitonin-gene-related-peptide-cgrp-inhibitors Calcitonin Gene-Related Peptide (CGRP) Inhibitors & Gastrointestinal Hypomotility, Constipation or GI dysmotility with Serious Complications and Intentional Self-Harm Studies
Calcitonin Gene-Related Peptide (CGRP) Inhibitors & Gastrointestinal Hypomotility, Constipation or GI dysmotility with Serious Complications and Intentional Self-Harm
Studies
https://sentinelinitiative.org/news-events/publications-presentations/health-information-exchanges-hies-novel-sources-population Health Information Exchanges (HIEs) as Novel Sources for Population-Based Post Marketing Surveillance of Medical Products: A Pilot Study from the FDA Sentinel Innovation Center Publications and Presentations
Health Information Exchanges (HIEs) as Novel Sources for Population-Based Post Marketing Surveillance of Medical Products: A Pilot Study from the FDA Sentinel Innovation Center
Publications and Presentations
https://sentinelinitiative.org/studies/drugs/confounding-covariates Confounding Covariates & Characterization Studies
Confounding Covariates & Characterization
Studies
https://sentinelinitiative.org/news-events/publications-presentations/identifying-covid-19-disease-severity-real-world-data Identifying COVID-19 Disease Severity in Real-World Data: Implications for Medical Product Effectiveness Studies Publications and Presentations
Identifying COVID-19 Disease Severity in Real-World Data: Implications for Medical Product Effectiveness Studies
Publications and Presentations
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/gastrointestinal-hypomotility-algorithm-defined-risk Gastrointestinal Hypomotility Algorithm Defined in "Risk of Gastrointestinal Hypomotility, Constipation, or GI Dysmotility with Serious Complications and Intentional Self-Harm in Individuals with Migraine Following Use of CGRP Inhibitors: A Propensity Score Matched Analysis" Methods, Data, & Tools
Gastrointestinal Hypomotility Algorithm Defined in "Risk of Gastrointestinal Hypomotility, Constipation, or GI Dysmotility with Serious Complications and Intentional Self-Harm in Individuals with Migraine Following Use of CGRP Inhibitors: A Propensity Score Matched Analysis"
Methods, Data, & Tools
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/constipation-algorithm-defined-risk-gastrointestinal Constipation Algorithm Defined in "Risk of Gastrointestinal Hypomotility, Constipation, or GI Dysmotility with Serious Complications and Intentional Self-Harm in Individuals with Migraine Following Use of CGRP Inhibitors: A Propensity Score Matched Analysis" Methods, Data, & Tools
Constipation Algorithm Defined in "Risk of Gastrointestinal Hypomotility, Constipation, or GI Dysmotility with Serious Complications and Intentional Self-Harm in Individuals with Migraine Following Use of CGRP Inhibitors: A Propensity Score Matched Analysis"
Methods, Data, & Tools
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/gastrointestinal-hypomotility-constipation-or-gi Gastrointestinal Hypomotility, Constipation, or GI Dysmotility with Serious Complications Algorithm Defined in "Risk of Gastrointestinal Hypomotility, Constipation, or GI Dysmotility with Serious Complications and Intentional Self-Harm in Individuals with Migraine Following Use of CGRP Inhibitors: A Propensity Score Matched Analysis" Methods, Data, & Tools
Gastrointestinal Hypomotility, Constipation, or GI Dysmotility with Serious Complications Algorithm Defined in "Risk of Gastrointestinal Hypomotility, Constipation, or GI Dysmotility with Serious Complications and Intentional Self-Harm in Individuals with Migraine Following Use of CGRP Inhibitors: A Propensity Score Matched Analysis"
Methods, Data, & Tools
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/intentional-self-harm-algorithm-defined-risk Intentional Self-Harm Algorithm Defined in "Risk of Gastrointestinal Hypomotility, Constipation, or GI Dysmotility with Serious Complications and Intentional Self-Harm in Individuals with Migraine Following Use of CGRP Inhibitors: A Propensity Score Matched Analysis" Methods, Data, & Tools
Intentional Self-Harm Algorithm Defined in "Risk of Gastrointestinal Hypomotility, Constipation, or GI Dysmotility with Serious Complications and Intentional Self-Harm in Individuals with Migraine Following Use of CGRP Inhibitors: A Propensity Score Matched Analysis"
Methods, Data, & Tools
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/paralytic-ileus-or-intestinal-obstruction-without Paralytic Ileus or Intestinal Obstruction Without Hernia Algorithm Defined in "Risk of Gastrointestinal Hypomotility, Constipation, or GI Dysmotility with Serious Complications and Intentional Self-Harm in Individuals with Migraine Following Use of CGRP Inhibitors: A Propensity Score Matched Analysis" Methods, Data, & Tools
Paralytic Ileus or Intestinal Obstruction Without Hernia Algorithm Defined in "Risk of Gastrointestinal Hypomotility, Constipation, or GI Dysmotility with Serious Complications and Intentional Self-Harm in Individuals with Migraine Following Use of CGRP Inhibitors: A Propensity Score Matched Analysis"
Methods, Data, & Tools
https://sentinelinitiative.org/studies/drugs/combined-hormonal-contraceptives Combined Hormonal Contraceptives & Venous Thromboembolism Studies
Combined Hormonal Contraceptives & Venous Thromboembolism
Studies
https://sentinelinitiative.org/methods-data-tools/health-outcomes-interest/venous-thromboembolism-algorithm-defined-use-combined Venous Thromboembolism Algorithm Defined in "Use of Combined Hormonal Contraceptives or Progestin-only Contraceptives During 6-month Postpartum Period and the Risk of Venous Thromboembolism: A Propensity Score Matched Analysis" Methods, Data, & Tools
Venous Thromboembolism Algorithm Defined in "Use of Combined Hormonal Contraceptives or Progestin-only Contraceptives During 6-month Postpartum Period and the Risk of Venous Thromboembolism: A Propensity Score Matched Analysis"
Methods, Data, & Tools
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/use-combined-hormonal-contraceptives-or-progestin-only Use of Combined Hormonal Contraceptives or Progestin-only Contraceptives During 6-month Postpartum Period and the Risk of Venous Thromboembolism: A Propensity Score Matched Analysis Analyses
Use of Combined Hormonal Contraceptives or Progestin-only Contraceptives During 6-month Postpartum Period and the Risk of Venous Thromboembolism: A Propensity Score Matched Analysis
Analyses
https://sentinelinitiative.org/news-events/publications-presentations/stroke-and-bleeding-risks-non-vitamin-k-oral-anticoagulants Stroke and Bleeding Risks with Non-Vitamin K Oral Anticoagulants in Nonvalvular Atrial Fibrillation Publications and Presentations
Stroke and Bleeding Risks with Non-Vitamin K Oral Anticoagulants in Nonvalvular Atrial Fibrillation
Publications and Presentations
https://sentinelinitiative.org/news-events/publications-presentations/association-between-race-and-covid-19-outcomes-during-pre Association Between Race and COVID-19 Outcomes During the Pre-Vaccination Period in the United States (2020-2021) Publications and Presentations
Association Between Race and COVID-19 Outcomes During the Pre-Vaccination Period in the United States (2020-2021)
Publications and Presentations
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/counts-and-characterization-mortality-capture-among-long Counts of and Characterization of Mortality Capture Among Long-Acting Injectable Antipsychotic (LAIA) Users: A Descriptive Analysis Analyses
Counts of and Characterization of Mortality Capture Among Long-Acting Injectable Antipsychotic (LAIA) Users: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/mortality-following-long-acting-injectable-antipsychotics-0 Mortality Following Long-Acting Injectable Antipsychotics Use: An Updated Inverse Probability of Treatment Weighting Analysis Assessments
Mortality Following Long-Acting Injectable Antipsychotics Use: An Updated Inverse Probability of Treatment Weighting Analysis
Assessments
https://sentinelinitiative.org/studies/drugs/long-acting-injectable-antipsychotics Long-Acting Injectable Antipsychotics & Mortality Studies
Long-Acting Injectable Antipsychotics & Mortality
Studies
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/mortality-following-long-acting-injectable-antipsychotics-1 Mortality Following Long-Acting Injectable Antipsychotics Use: A Third Inverse Probability of Treatment Weighting Analysis Analyses
Mortality Following Long-Acting Injectable Antipsychotics Use: A Third Inverse Probability of Treatment Weighting Analysis
Analyses
https://sentinelinitiative.org/news-events/publications-presentations/plasmode-simulation-based-bias-analysis-residual-confounding A Plasmode Simulation-Based Bias Analysis for Residual Confounding by Unmeasured Variables Leveraging Information-Rich Subsets Publications and Presentations
A Plasmode Simulation-Based Bias Analysis for Residual Confounding by Unmeasured Variables Leveraging Information-Rich Subsets
Publications and Presentations
https://sentinelinitiative.org/studies/drugs/clozapine Clozapine & Adherence to Absolute Neutrophil Count (ANC) Monitoring and Neutropenia Studies
Clozapine & Adherence to Absolute Neutrophil Count (ANC) Monitoring and Neutropenia
Studies
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-infliximab-biosimilar-product Outcome Monitoring Following Infliximab Biosimilar Product Use: An Active Comparator Signal Identification Analysis Analyses
Outcome Monitoring Following Infliximab Biosimilar Product Use: An Active Comparator Signal Identification Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-sentinel-prescribing-and-dispensing-tables Characterization of the Sentinel Prescribing and Dispensing Tables: A Descriptive Analysis Analyses
Characterization of the Sentinel Prescribing and Dispensing Tables: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/dihydropyrimidine-dehydrogenase-dpyd-gene-variant-testing Dihydropyrimidine Dehydrogenase (DPYD) Gene Variant Testing Rates and Fluoropyrimidine Use Following Pharmacogenetic Testing Among Incident Fluoropyrimidine Users: A Descriptive Analysis Analyses
Dihydropyrimidine Dehydrogenase (DPYD) Gene Variant Testing Rates and Fluoropyrimidine Use Following Pharmacogenetic Testing Among Incident Fluoropyrimidine Users: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/news-events/publications-presentations/effectiveness-and-safety-cannabis-anxiety-treatment-outcomes Effectiveness and Safety of Cannabis on Anxiety Treatment Outcomes: A Systematic Review Publications and Presentations
Effectiveness and Safety of Cannabis on Anxiety Treatment Outcomes: A Systematic Review
Publications and Presentations
https://sentinelinitiative.org/news-events/publications-presentations/effectiveness-thc-containing-cannabis-inflammatory-bowel Effectiveness of THC-Containing Cannabis for Inflammatory Bowel Disease: A Systematic Review Publications and Presentations
Effectiveness of THC-Containing Cannabis for Inflammatory Bowel Disease: A Systematic Review
Publications and Presentations
https://sentinelinitiative.org/studies/drugs/semaglutide-injectables Semaglutide Injectables & Signal Identification Studies
Semaglutide Injectables & Signal Identification
Studies
https://sentinelinitiative.org/studies/drugs/infliximab-biosimilars Infliximab Biosimilars & Signal Identification Studies
Infliximab Biosimilars & Signal Identification
Studies
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/prevalence-cutaneous-lupus-erythematosus-sentinel Prevalence of Cutaneous Lupus Erythematosus in the Sentinel Distributed Database: A Descriptive Analysis Analyses
Prevalence of Cutaneous Lupus Erythematosus in the Sentinel Distributed Database: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/cutaneous-lupus-erythematosus Cutaneous Lupus Erythematosus & Prevalence Studies
Cutaneous Lupus Erythematosus & Prevalence
Studies
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/ketamine-use-patients-emergency-department-encounters Ketamine Use in Patients with Emergency Department Encounters: A Descriptive Analysis Analyses
Ketamine Use in Patients with Emergency Department Encounters: A Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/ketamine-use-patients-emergency-department-encounters-second Ketamine Use in Patients with Emergency Department Encounters: A Second Descriptive Analysis Analyses
Ketamine Use in Patients with Emergency Department Encounters: A Second Descriptive Analysis
Analyses
https://sentinelinitiative.org/studies/drugs/covid-19-outcomes COVID-19 Patients & Racial and Ethnic Differences Studies
COVID-19 Patients & Racial and Ethnic Differences
Studies
https://sentinelinitiative.org/studies/drugs/ketamine Ketamine & Emergency Department and Pre-Hospital Use Studies
Ketamine & Emergency Department and Pre-Hospital Use
Studies